#	Pagina
attuale pagina	/open-h2020/projects/196513/index.html

Opendata, web and dolomites

MD

Rapid monitoring of biomarkers in postoperative care

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

MD project word cloud

Explore the words cloud of the MD project. It provides you a very rough idea of what is the project "MD" about.

medical biomedical care cancer innovative possibility sampling complications radically save improves diagnosed surface bowel economic world relatively systemic counteractions surgery ab illness monitoring stage feasibility plan detect colorectal missing treatment functional business safe attached divided biomakers indications minutes rapid patient environmental million frequency 2012 deliverable health measurable nearly piece report md gently

Project "MD" data sheet

The following table provides information about the project.

Coordinator	MD BIOMEDICAL AB Organization address address: PO POX 7995 city: UMEA postcode: 90719 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Sweden [SE]
Project website	http://www.mdbiomedical.se
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-05-01 to 2015-10-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	MD BIOMEDICAL AB MD BIOMEDICAL AB Organization address address: PO POX 7995 city: UMEA postcode: 90719 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (UMEA)	coordinator	50˙000.00

Map

Project objective

Colorectal cancer is the third most common cancer in the world, with nearly 1.4 million new cases diagnosed in 2012. The frequency of complications after surgery is relatively high, but rapid and safe monitoring methods are missing.

MD Biomedical AB has addressed this need and developed a radically new and innovative piece of medical equipment that is gently attached on the surface of the bowel for sampling of biomakers. This makes it possible to detect complications within minutes, at an early stage of illness, and long before patient systemic indications.

The possibility of rapid counteractions improves the treatment of the patient and save health care costs.

The feasibility study comprises one work package divided in 6 tasks and shall in measurable terms assess the functional, medical, economic, and environmental effects and the deliverable is a feasibility report including a business plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials